Pulmicort respules and Accolate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pulmicort respules (budesonide) and Accolate (zafirlukast). Common drug interactions include diabetes mellitus among females and aphonia among males.

The phase IV clinical study analyzes what interactions people have when they take Pulmicort respules and Accolate. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Pulmicort respules?

Pulmicort respules has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 2,321 Pulmicort respules users. Check the latest studies of Pulmicort respules.

What is Accolate?

Accolate has active ingredients of zafirlukast. It is often used in asthma. eHealthMe is studying from 4,220 Accolate users. Check the latest studies of Accolate.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 29, 2026

12 people who take Pulmicort respules and Accolate together, and have interactions are studied.

Pulmicort respules and Accolate drug interactions.

What are the common drug interactions of Pulmicort Respules and Accolate, by gender? *:

female:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Adverse event
  3. Anxiety disorder
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Depression
  6. Herpes zoster
  7. Mycotic allergy (fungal allergy)
  8. Respiratory disorder (respiratory disease)
  9. Chest discomfort
  10. Confusional state

male:

  1. Aphonia (inability to produce voice)
  2. Asthenia (weakness)
  3. Infection
  4. Pneumonia
  5. Productive cough
  6. Prolonged expiration (person's difficulty in breathing)
  7. Pulmonary mass
  8. Pyrexia (fever)
  9. Respiratory disorder (respiratory disease)
  10. Sputum discoloured

What are the common drug interactions of Pulmicort Respules and Accolate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Anxiety disorder
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Depression
  4. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  5. Herpes zoster
  6. Mycotic allergy (fungal allergy)
  7. Respiratory disorder (respiratory disease)
  8. Hypertension (high blood pressure)
  9. Injection site pain
  10. Muscle spasms (muscle contraction)

30-39:

n/a

40-49:

n/a

50-59:

  1. Confusional state
  2. Cough
  3. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  4. Drug intolerance (drug sensitivity)
  5. Dysphonia (speech disorder attributable to a disorder of phonation)
  6. Fall
  7. Gastric disorder (disease of stomach)
  8. Hearing impaired
  9. Neoplasm malignant (cancer tumour)
  10. Neuralgia (pain in one or more nerves)

60+:

  1. Adverse event
  2. Chest discomfort
  3. Colon cancer
  4. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  5. Dyspnoea (difficult or laboured respiration)
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Metastases to liver (cancer spreads to liver)
  8. Metastases to lung (cancer spreads to lung)
  9. Weight decreased

What are the existing conditions these people have? *

  1. Thyroid Diseases: 1 person, 8.33%
  2. Stress And Anxiety: 1 person, 8.33%
  3. Sleep Disorder: 1 person, 8.33%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 8.33%
  5. Pain: 1 person, 8.33%
  6. Muscle Spasms (muscle contraction): 1 person, 8.33%
  7. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 8.33%
  8. High Blood Pressure: 1 person, 8.33%
  9. High Blood Cholesterol: 1 person, 8.33%
  10. Heart Attack: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Pulmicort respules and Accolate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pulmicort respules and Accolate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pulmicort respules:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Accolate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pulmicort respules and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Accolate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on budesonide and zafirlukast (the active ingredients of Pulmicort respules and Accolate, respectively), and Pulmicort respules and Accolate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: